Lindsay Collin1, Sari L Reisner2, Vin Tangpricha3, Michael Goodman4. 1. Rollins School of Public Health, Emory University, Atlanta, GA, USA. 2. The Fenway Institute, Fenway Health, Boston, MA, USA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. 3. School of Medicine, Emory University, Atlanta, GA, USA. 4. Rollins School of Public Health, Emory University, Atlanta, GA, USA. Electronic address: mgoodm2@emory.edu.
Abstract
INTRODUCTION: A systematic review and meta-analysis was conducted to evaluate how various definitions of transgender affect prevalence estimates. AIMS: To evaluate the epidemiology of transgender and examine how various definitions of transgender affect prevalence estimates and to compare findings across studies that used different methodologies, in different countries, and over different periods. METHODS: PubMed, EMBASE, and Medline were searched to identify studies reporting prevalence estimates of transgender in a population. All studies were grouped based on the case definition applied to the numerator. Summary estimates were derived using a random-effects model for total prevalence of transgender and for male-to-female and female-to-male subgroups. Overall and stratum-specific meta-prevalence estimates (mPs) and 95% confidence intervals (CIs) were accompanied by tests for heterogeneity and meta-regressions to assess sources of heterogeneity. MAIN OUTCOME MEASURES: The main outcome measure was population prevalence of transgender. Secondary outcomes included gender-specific prevalence estimates for male-to-female and female to male subgroups. RESULTS: Thirty-two studies met the inclusion criteria for systematic review. Of those, 27 studies provided necessary data for a meta-analysis. Overall mP estimates per 100,000 population were 9.2 (95% CI = 4.9-13.6) for surgical or hormonal gender affirmation therapy and 6.8 (95% CI = 4.6-9.1) for transgender-related diagnoses. Of studies assessing self-reported transgender identity, the mP was 871 (95% CI = 519-1,224); however, this result was influenced by a single outlier study. After removal of that study, the mP changed to 355 (95% CI = 144-566). Significant heterogeneity was observed in most analyses. CONCLUSION: The empirical literature on the prevalence of transgender highlights the importance of adhering to specific case definitions because the results can range by orders of magnitude. Standardized and routine collection of data on transgender status and gender identity is recommended.
INTRODUCTION: A systematic review and meta-analysis was conducted to evaluate how various definitions of transgender affect prevalence estimates. AIMS: To evaluate the epidemiology of transgender and examine how various definitions of transgender affect prevalence estimates and to compare findings across studies that used different methodologies, in different countries, and over different periods. METHODS: PubMed, EMBASE, and Medline were searched to identify studies reporting prevalence estimates of transgender in a population. All studies were grouped based on the case definition applied to the numerator. Summary estimates were derived using a random-effects model for total prevalence of transgender and for male-to-female and female-to-male subgroups. Overall and stratum-specific meta-prevalence estimates (mPs) and 95% confidence intervals (CIs) were accompanied by tests for heterogeneity and meta-regressions to assess sources of heterogeneity. MAIN OUTCOME MEASURES: The main outcome measure was population prevalence of transgender. Secondary outcomes included gender-specific prevalence estimates for male-to-female and female to male subgroups. RESULTS: Thirty-two studies met the inclusion criteria for systematic review. Of those, 27 studies provided necessary data for a meta-analysis. Overall mP estimates per 100,000 population were 9.2 (95% CI = 4.9-13.6) for surgical or hormonal gender affirmation therapy and 6.8 (95% CI = 4.6-9.1) for transgender-related diagnoses. Of studies assessing self-reported transgender identity, the mP was 871 (95% CI = 519-1,224); however, this result was influenced by a single outlier study. After removal of that study, the mP changed to 355 (95% CI = 144-566). Significant heterogeneity was observed in most analyses. CONCLUSION: The empirical literature on the prevalence of transgender highlights the importance of adhering to specific case definitions because the results can range by orders of magnitude. Standardized and routine collection of data on transgender status and gender identity is recommended.
Authors: Eva Van Caenegem; Katrien Wierckx; Els Elaut; Ann Buysse; Alexis Dewaele; Filip Van Nieuwerburgh; Griet De Cuypere; Guy T'Sjoen Journal: Arch Sex Behav Date: 2015-01-15
Authors: Randi H Goldman; Daniel J Kaser; Stacey A Missmer; Leslie V Farland; Rachel K Ashby; Elizabeth S Ginsburg Journal: J Assist Reprod Genet Date: 2017-09-12 Impact factor: 3.412
Authors: John R Blosnich; John Cashy; Adam J Gordon; Jillian C Shipherd; Michael R Kauth; George R Brown; Michael J Fine Journal: J Am Med Inform Assoc Date: 2018-07-01 Impact factor: 4.497